AEON Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.4%.

Top 25 shareholders own 70.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.6%	Daewoong Co., Ltd.	4,177,604	US$2.2m	0%	no data
9.3%	Atalaya Capital Management LP	3,675,000	US$1.9m	0%	4.09%
9.11%	Polar Asset Management Partners Inc.	3,599,918	US$1.9m	-2.04%	0.07%
8.99%	Priveterra Sponsor, LLC	3,555,000	US$1.9m	-48.5%	no data
8.45%	Blue Owl Capital, Investment Arm	3,341,204	US$1.8m	0%	0.76%
6.07%	Daewoong Pharmaceutical Co., Ltd	2,400,000	US$1.3m	0%	no data
5.73%	Robert Palmisano	2,265,000	US$1.2m	0%	no data
5.24%	Crown Holdings LLC	2,070,081	US$1.1m	0%	100.0%
1.9%	The Vanguard Group, Inc.	751,343	US$398.3k	0%	no data
0.99%	Formidable Asset Management, LLC	389,782	US$206.6k	243%	0.04%
0.67%	BlackRock, Inc.	265,150	US$140.6k	-2.63%	no data
0.65%	Ikarian Capital, LLC	257,977	US$136.8k	0%	0.04%
0.62%	Geode Capital Management, LLC	243,168	US$128.9k	30.1%	no data
0.42%	Bank of America Corporation, Asset Management Arm	166,600	US$88.3k	620%	no data
0.18%	Marc Forth	69,963	US$37.1k	0%	no data
0.16%	Two Sigma Investments, LP	65,208	US$34.6k	0%	no data
0.16%	The Caprock Group, LLC	62,686	US$33.2k	0%	no data
0.15%	State Street Global Advisors, Inc.	60,950	US$32.3k	0%	no data
0.15%	UBS Asset Management AG	57,635	US$30.6k	0%	no data
0.14%	Boothbay Fund Management, LLC	55,062	US$29.2k	0%	no data
0.13%	Northern Trust Global Investments	51,928	US$27.5k	0%	no data
0.12%	LMR Partners LLP	48,901	US$25.9k	-11%	no data
0.11%	Jost Fischer	43,770	US$23.2k	0%	no data
0.068%	LPL Financial Corporation, Asset Management Arm	26,840	US$14.2k	0%	no data
0.064%	Chad Oh	25,107	US$13.3k	0%	no data